Company Overview and News

 
Shares up, led by NZ Refining

2018-08-24 nzherald.co.nz
New Zealand shares rose, led by New Zealand Refining Co and Port of Tauranga. Sky Network Television dropped back after it turned to a loss in 2018.
TME TRMEF WBC WEBNF NZR WBK SKT SYKWF WBC MPP TME MTPGF SKKTY TDMEY

 
MARKET WRAP: NZ shares rise: Serko up, Evolve down

2018-07-31 nbr.co.nz
New Zealand shares rose today as Serko and Evolve Education shares went in opposite directions in response to guidance updates.
CEN COENF MPP CEN MTPGF FGHRY EVO FLT COENY

1
Brian Gaynor: KiwiSavers should surf wave of cash

2018-07-13 nzherald.co.nz - 1
The world is awash with cash, and private equity (PE) funds are a clear example of this phenomenon.
IQE RHCGF IQE MPP RYHTY MTPGF RYM

12
Brian Gaynor: Bring greater diversity to the boardroom

2018-06-29 nzherald.co.nz
The Blues' success in the State of Origin thriller and the referee's decisions that supposedly robbed the Wallabies against Ireland weren't the only topics of conversation in Sydney this week.
WYN FBU FBU ANZLY AIR MPP FCREY MTPGF ANZFF ANZFY FRCEF AIZ

2
Sharemarket overvalued, rally hard to justify - Forsyth Barr

2018-06-10 nzherald.co.nz
The sharemarket looks over valued as investors fail to price in uncertainty from the new Government's policies and rising costs, says brokers Forsyth Barr.
ZNZ MPP ZNRGF MTPGF ZEL AUG

2
MARKET WRAP: NZ shares rise despite global dairy prices slipping

2018-06-06 nbr.co.nz
Fat Prophets head of research Greg Smith says investors are 'lapping up' F&P Healthcare's record result.
MPP MTPGF SML

 
Glass manufacturer's profit falls with soft market

2018-05-25 radionz.co.nz
Metro Performance Glass has delivered a disappointing result with net profit down 16 percent on last year.
MPP MTPGF

2
MARKET WRAP: NZ shares fall with Comvita and A2 Milk

2018-05-21 nbr.co.nz
New Zealand shares fell today, led by a poor day of trading for Comvita and A2 Milk.
SKT SYKWF MPP MTPGF SKKTY KWIPF

34
Shares rise as investors second guess index changes; Fletcher gains

2018-05-08 nzherald.co.nz
New Zealand shares rose, joining a regional rally, as investors predict whether an upcoming MSCI index review will spur major activity next week. Fletcher Building, which could exit the index, gains, while new addition a2 Milk Co fell.
CEN TME TRMEF PYIYY AIR FCREY NZTCF ACKDF ANZFY AUKNY AIZ KMD COENF TME CEN KMD KTHDY AIA FBU WBC SPKKY NZTCY SPK WEBNF WBK FRCEF COENY AIA WBC FBU ANZLY MPP MTPGF ANZFF TDMEY MEZ PFI

11
Shares rise as Fletcher jumps on Wesfarmers report

2018-04-13 nzherald.co.nz - 1
New Zealand's benchmark S&P/NZX 50 Index rose, with much of the gain driven by Fletcher Building shares, which lifted on a report Australia's Wesfarmers has taken a small stake. Mercury NZ led decliners and A2 Milk fell on concerns it could be hurt by rivalry in sales of dairy products with the A2 protein variant.
ZNZ SMP FBU SKC FBU MPP FCREY MTPGF ZNRGF FRCEF ZEL SML

 
MARKET WRAP: NZ shares up slightly, Orion down again

2018-04-10 nbr.co.nz
New Zealand shares stayed just above water today, with wins from Pushpay and IkeGPS overcoming further losses for Orion Health.
MPP MTPGF

3
MARKET CLOSE: NZ shares hit record amidst rebalancing, Comvita and Sky TV gain while Pushpay, A2 drop

2018-03-16 nbr.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.
SKT SYKWF VIL PPSHY MPP MTPGF SKKTY GTK

3
NZ shares hit record amidst rebalancing

2018-03-16 nzherald.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.
SKT SYKWF VIL PPSHY MPP MTPGF SKKTY GTK

17
MARKET CLOSE: NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nbr.co.nz
(BusinessDesk) - New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent weakness and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.
FBU FCREY SPKKY EBOSY NZTCY SPK NZTCF FRCEF PGW EBO PGWFY GRO SKT EBOSF SYKWF FBU MPP MTPGF SKKTY PGWFF EBO

17
NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nzherald.co.nz
New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent selling and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.
FBU FCREY SPKKY EBOSY NZTCY SPK NZTCF FRCEF PGW EBO PGWFY GRO SKT EBOSF SYKWF FBU MPP MTPGF SKKTY PGWFF EBO

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...